Detection of anti-infliximab antibodies is impacted by antibody titer, infliximab level and IgG4 antibodies: a systematic comparison of three different assays (Q41551453)

From Wikidata

Jump to navigation Jump to search

scientific article published on 26 July 2016

Language	Label	Description	Also known as
English	Detection of anti-infliximab antibodies is impacted by antibody titer, infliximab level and IgG4 antibodies: a systematic comparison of three different assays	scientific article published on 26 July 2016

Statements

scholarly article

1 reference

Europe PubMed Central

3 October 2017

Detection of anti-infliximab antibodies is impacted by antibody titer, infliximab level and IgG4 antibodies: a systematic comparison of three different assays (English)

1 reference

Europe PubMed Central

3 October 2017

Claudia Camila Dias

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27803733%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Shomron Ben-Horin

23

object named as

Shomron Ben-Horin

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27803733%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

Joana Afonso

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27803733%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Susana Lopes

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27803733%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Raquel Gonçalves

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27803733%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Paulo Caldeira

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27803733%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Paula Lago

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27803733%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Helena Tavares de Sousa

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27803733%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Jaime Ramos

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27803733%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Ana Rita Gonçalves

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27803733%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Paula Ministro

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27803733%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Isadora Rosa

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27803733%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Ana Isabel Vieira

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27803733%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Rosa Coelho

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27803733%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Patrícia Tavares

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27803733%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

João Soares

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27803733%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Ana Lúcia Sousa

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27803733%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Diana Carvalho

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27803733%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Paula Sousa

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27803733%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

João Pereira da Silva

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27803733%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Tânia Meira

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27803733%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Filipa Silva Ferreira

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27803733%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Yehuda Chowers

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27803733%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Fernando Magro

24

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27803733%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

on behalf Portuguese IBD Study Group (GEDII)

25

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27803733%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

publication date

26 July 2016

1 reference

Europe PubMed Central

3 October 2017

Therapeutic Advances in Gastroenterology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27803733%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27803733%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

781-794

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27803733%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27803733%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Using monoclonal antibodies as an international standard for the measurement of anti-adalimumab antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5076767

6 June 2018

Significance of low level infliximab in the absence of anti-infliximab antibodies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5076767

6 June 2018

The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5076767

6 June 2018

Use of infliximab and anti-infliximab antibody measurements to evaluate and optimize efficacy and safety of infliximab maintenance therapy in Crohn's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5076767

6 June 2018

Personalized medicine: theranostics (therapeutics diagnostics) essential for rational use of tumor necrosis factor-alpha antagonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5076767

6 June 2018

Assessing response and loss of response to biological therapies in IBD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5076767

6 June 2018

The Measurement of Observer Agreement for Categorical Data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5076767

6 June 2018

Association between serum concentration of infliximab and efficacy in adult patients with ulcerative colitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5076767

19 August 2018

Development of an algorithm incorporating pharmacokinetics of adalimumab in inflammatory bowel diseases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5076767

19 August 2018

Clinical implications of measuring drug and anti-drug antibodies by different assays when optimizing infliximab treatment failure in Crohn's disease: post hoc analysis of a randomized controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5076767

19 August 2018

Individualised therapy is more cost-effective than dose intensification in patients with Crohn's disease who lose response to anti-TNF treatment: a randomised, controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5076767

19 August 2018

Comparison of techniques for monitoring infliximab and antibodies against infliximab in Crohn's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5076767

19 August 2018

Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5076767

19 August 2018

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

1 reference

https://api.crossref.org/works/10.1177%2F1756283X16658223

21 January 2018

The immunogenic part of infliximab is the F(ab')2, but measuring antibodies to the intact infliximab molecule is more clinically useful

1 reference

https://pubmed.ncbi.nlm.nih.gov/27803733

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical utility of antihuman lambda chain-based enzyme-linked immunosorbent assay (ELISA) versus double antigen ELISA for the detection of anti-infliximab antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/27803733

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levels of drug and antidrug antibodies are associated with outcome of interventions after loss of response to infliximab or adalimumab

1 reference

https://pubmed.ncbi.nlm.nih.gov/27803733

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of a new immunoassay for the accurate determination of anti-infliximab antibodies in inflammatory bowel disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/27803733

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1177/1756283X16658223

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27803733%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27803733%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27803733%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41551453&oldid=1924300295"